Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations
Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...
Innovent Biologics: Innovent and ASK Pharm Jointly Announce NMPA Approval of Limertinib, a Third-generation EGFR TKI for the Treatment of Lung Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Price Target at $14.83
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from ...
Pharmabiz27m
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr
Innovent Biologics, ASK Pharm announce China’s NMPA approval of limertinib to treat metastatic EGFR T790M-mutated NSCLCr: San Francisco Saturday, January 18, 2025, 09:00 Hrs [IS ...
Exxon Mobil and Chevron Megadeals Are Cleared of FTC Antitrust Concerns
Pioneer Natural Resources’ former CEO and Hess’s CEO are prohibited from serving on the oil companies’ boards ...